COYA Earnings Coya Therapeutics, Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–18 of 18
| Q1 2026 | 2026-03-31 | -0.32 | 2026-05-12 | 10-Q |
| FY 2025 | 2025-12-31 | -1.27 | 2026-03-16 | 10-K |
| Q3 2025 | 2025-09-30 | -0.93 | 2025-11-12 | 10-Q |
| Q2 2025 | 2025-06-30 | -0.80 | 2025-08-12 | 10-Q |
| Q1 2026 | 2025-03-31 | -0.44 | 2026-05-12 | 10-Q |
| FY 2025 | 2024-12-31 | -0.98 | 2026-03-16 | 10-K |
| Q3 2025 | 2024-09-30 | -0.80 | 2025-11-12 | 10-Q |
| Q2 2025 | 2024-06-30 | -0.54 | 2025-08-12 | 10-Q |
| Q1 2025 | 2024-03-31 | -0.35 | 2025-05-13 | 10-Q |
| FY 2024 | 2023-12-31 | -0.79 | 2025-03-18 | 10-K |
| Q3 2024 | 2023-09-30 | -0.94 | 2024-11-06 | 10-Q |
| Q2 2024 | 2023-06-30 | -0.59 | 2024-08-12 | 10-Q |
| Q1 2024 | 2023-03-31 | -0.28 | 2024-05-09 | 10-Q |
| FY 2023 | 2022-12-31 | -4.73 | 2024-03-19 | 10-K |
| Q3 2023 | 2022-09-30 | -3.53 | 2023-11-08 | 10-Q |
| Q2 2023 | 2022-06-30 | -1.98 | 2023-08-08 | 10-Q |
| Q1 2023 | 2022-03-31 | -0.66 | 2023-05-10 | 10-Q |
| FY 2022 | 2021-12-31 | -1.89 | 2023-03-29 | 10-K |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.